Breast Lesion Localization Market Share, Size, Trends, Industry Analysis Report, By Type (Wire, Radioisotope, Magnetic, Electromagnetic Localization); By Usage; By End User; By Region; Segment Forecast, 2023- 2032

Breast Lesion Localization Market Share, Size, Trends, Industry Analysis Report, By Type (Wire, Radioisotope, Magnetic, Electromagnetic Localization); By Usage; By End User; By Region; Segment Forecast, 2023- 2032

The global breast lesion localization market size is expected to reach USD 546.74 million by 2032, according to a new study by Polaris Market Research. The report “Breast Lesion Localization Market Share, Size, Trends, Industry Analysis Report, By Type (Wire, Radioisotope, Magnetic, Electromagnetic Localization); By Usage; By End User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The ongoing research activities on breast lesion localization are creating awareness among surgeons about the latest technologies in the global market. A study published in Science Direct in 2022 focused on the analysis of pre-operative breast & axillary localizations. They prepared a questionnaire and circulated it to the Society of Breast Imaging Physicians. They witnessed a correlation between academics and the use of radioactive seeds. Wireless localization devices were more prevalent in practices, with a larger proportion of radiologists who read mammography.

The number of breast radiologists with fellowship training in a practice was significantly correlated positively with the methods used to localize breast lesions. This study reveals that different practice types use different localization techniques for breast and axillary lesions. They found that wireless localization devices are more likely to be used in academic settings, and integrating the use of modern localization techniques may provide challenges for smaller and less specialised practices. This facilitates further research activities on the applications of different technologies to various conditions, which may assist doctors in choosing effective tools for particular health conditions for their patients.

A study published in 2023 in PubMed Central focused on a systematic review of the localization technologies used by surgeons in treating non-palpable breast lesions. The most popular method out of those that are available is wire-guided localization (WGL). In the past twenty years, other methods (radioactive, magnetic, radar- or radiofrequency-based, and intraoperative ultrasound) have been developed with the goal of enhancing results and logistics. The study concluded that wire-free localization is preferred by patients more often, according to smaller research, but little is known about how surgeons and radiologists feel about these methods, facilitating a scope for future research activities on surgeon preferences towards various localization technologies. The rising research activities will create growth potential for the breast lesion localization market in the coming years.

Breast Lesion Localization Market Report Highlights

Electromagnetic segment is anticipated to witness the highest growth in the coming years due to its higher effectiveness.

Breast Conservation segment accounted for the largest market share owing to rising concerns about breast appearance.

Ambulatory surgical center segment is projected to experience a larger revenue share due to its growing adoption.

North America is projected to register a largest growth rate in the study period owing to the growing government initiatives to eliminate breast cancer.

Asia Pacific is expected to have the fastest growth owing to the rising prevalence of breast cancer.

The global players include Ambu, ARGON MEDICAL, Biomedical Srl, BPB Medica, Dragerwerk, Intramedical Imaging, Isoaid, Izi Medical Products & Koninklijke Philips.

Polaris Market Research has segmented the breast lesion localization market report based on type, usage, end user and region:

Breast Lesion Localization, Type Outlook (Revenue - USD Million, 2019 - 2032)

Wire Localization

Radioisotope Localization

Radioguided Occult Lesion Localization (ROLL)

Radioactive Seed Localization (RSL)

Magnetic Localization

Electromagnetic Localization

Other Localization Methods

Breast Lesion Localization, Usage Outlook (Revenue - USD Million, 2019 - 2032)

Breast Biopsy

Breast Conservation (Lumpectomy)

Breast Lesion Localization, End User Outlook (Revenue - USD Million, 2019 - 2032)

Hospitals & Clinics

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Others

Breast Lesion Localization, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa